SCIRX
Price
$117.78
Change
+$0.10 (+0.08%)
Updated
Jul 15 closing price
Net Assets
14.56B
STPIX
Price
$28.44
Change
+$0.13 (+0.46%)
Updated
Jul 15 closing price
Net Assets
42.32M
Interact to see
Advertisement

SCIRX vs STPIX

Header iconSCIRX vs STPIX Comparison
Open Charts SCIRX vs STPIXBanner chart's image
Columbia Seligman Tech & Info R
Price$117.78
Change+$0.10 (+0.08%)
VolumeN/A
Net Assets14.56B
Saratoga Technology & Comm I
Price$28.44
Change+$0.13 (+0.46%)
VolumeN/A
Net Assets42.32M
SCIRX vs STPIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
SCIRX vs. STPIX commentary
Jul 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SCIRX is a Buy and STPIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
SCIRX has more cash in the bank: 14.6B vs. STPIX (42.3M). SCIRX (0.00) and STPIX (0.00) have matching dividends . SCIRX was incepted earlier than STPIX: SCIRX (22 years) vs STPIX (23 years). STPIX (2.22) is less costly to investors than SCIRX (1.43). SCIRX is a more actively managed with annual turnover of: 39.00 vs. STPIX (8.00). SCIRX has a lower initial minimum investment than STPIX: SCIRX (0) vs STPIX (250). STPIX annual gain was more profitable for investors over the last year : -0.21 vs. SCIRX (-3.64). SCIRX return over 5 years is better than : 44.53 vs. STPIX (-1.56).
SCIRXSTPIXSCIRX / STPIX
Total Expense Ratio1.432.2264%
Annual Report Gross Expense Ratio1.432.2264%
Fund Existence22 years23 years-
Gain YTD5.8187.76675%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets14.6B42.3M34,515%
Annual Yield % from dividends0.000.00-
Returns for 1 year-3.64-0.211,723%
Returns for 3 years34.3525.27136%
Returns for 5 years44.53-1.56-2,846%
Returns for 10 years100.7555.46182%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GLUC0.10N/A
+3.11%
Glucose Health, Inc.
RLFTF2.790.03
+1.13%
RELIEF THERAPEUTICS HLDG AG
NDRBF4.66N/A
N/A
Nibe Industrier AB
OJIPF5.09N/A
N/A
Oji Holdings Corp
CSWYF1.00N/A
N/A
China Shineway Pharmaceutical Group Ltd.